Curevac share price today

(CVAC)

Curevac share price is $3.05 & ₹260.07 as on 27 Dec 2024, 2.30 'hrs' IST

$3.05

▲

0.06

(2.01%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Curevac share price in Dollar and Rupees. Guide to invest in Curevac from India. Also see the sentimental analysis on Indian investors investing in Curevac. Get details on the Indian mutual funds that are investing in Curevac. Get Analyst recommendations and forecasts along with all the Curevac's financials.

Curevac share price movements

Today's Low: $2.94
Today's High: $3.06
$3.05
3.77%
Downside
Day's Volatility :4.08%
Upside
0.33%
52 Weeks Low: $2.22
52 Weeks High: $5.28
$3.05
27.38%
Downside
52 Weeks Volatility :58.05%
Upside
42.23%

Curevac Returns

Period	Curevac	Sector (Health Care)	Index (Russel 2000)
3 Months	-0.33%	-9.0%	0.0%
6 Months	-12.06%	-4.6%	0.0%
1 Year	-30.14%	3.0%	0.0%
3 Years	-91.27%	0.0%	-21.1%

Curevac Key Statistics

in dollars & INR

Previous Close	$2.99
Open	$2.97
Today's High	$3.06
Today's Low	$2.935
Market Capitalization	$670.8M
Today's Volume	$176.5K
52 Week High	$5.28
52 Week Low	$2.215
Revenue TTM	$65.9M
EBITDA	$-270.3M
Earnings Per Share (EPS)	$0.49
PE Ratio	6.1
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-54.3%

How to invest in Curevac from India?

It is very easy for Indian residents to invest directly in Curevac from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Curevac stock in both Indian Rupees (INR) and US Dollars (USD). Search for Curevac or CVAC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Curevac or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Curevac shares which would translate to 0.280 fractional shares of Curevac as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Curevac, in just a few clicks!

Returns in Curevac for Indian investors in Rupees

Investment Value

₹1,00,000

Curevac investment value today

Current value as on today

₹73,587

Returns

₹26,413

(-26.41%)

Returns from Curevac Stock

₹28,738 (-28.74%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Curevac

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Curevac on INDmoney from India has grown in the last 30 days as on Dec 27, 2024. 7% more investors are searching Curevac in the last 30 days versus the previous period.

Global Institutional Holdings in Curevac

Millennium Management LLC
1.08%
BlackRock Inc
1.00%
Bill & Melinda Gates Foundation
0.70%
Citadel Advisors Llc
0.45%
Point72 Asset Management, L.P.
0.35%
Alyeska Investment Group, L.P.
0.18%

Analyst Recommendation on Curevac

Buy

66%Buy

26%Hold

6%Sell

Based on 15 Wall street analysts offering stock ratings for Curevac(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Curevac

What analysts predicted

Upside of 135.12%

Current:

$3.05

Target:

$7.17

Insights on Curevac

Price Movement
In the last 3 years, CVAC stock has moved down by -91.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 12.37M → 493.90M (in $), with an average increase of 55.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -72.54M → 338.04M (in $), with an average increase of 121.5% per quarter
CVAC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 53.9%
CVAC vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 117.1%
Price to Sales
ForCVAC every $1 of sales, investors are willing to pay $10.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Curevac Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$14.6M	-
Net Income	$-81.0M	-
Net Profit Margin	-553.5%	-

	FY19	Y/Y Change
Revenue	$19.4M	↑ 35.31%
Net Income	$-111.0M	↑ 40.19%
Net Profit Margin	-573.46%	↓ 19.96%

	FY20	Y/Y Change
Revenue	$59.5M	↑ 180.78%
Net Income	$-157.0M	↑ 29.24%
Net Profit Margin	-263.96%	↑ 309.5%

	FY21	Y/Y Change
Revenue	$116.4M	↑ 110.61%
Net Income	$-465.4M	↑ 218.98%
Net Profit Margin	-399.76%	↓ 135.8%

	FY22	Y/Y Change
Revenue	$71.3M	↓ 34.54%
Net Income	$-263.5M	↓ 39.51%
Net Profit Margin	-369.37%	↑ 30.39%

	FY23	Y/Y Change
Revenue	$58.6M	↓ 20.26%
Net Income	$-283.8M	↑ 4.47%
Net Profit Margin	-483.96%	↓ 114.59%

	Q2 FY23	Q/Q Change
Revenue	$8.2M	↓ 35.16%
Net Income	$-73.1M	↓ 47.65%
Net Profit Margin	-889.48%	↑ 212.27%

	Q3 FY23	Q/Q Change
Revenue	$17.6M	↑ 117.48%
Net Income	$-52.0M	↓ 27.79%
Net Profit Margin	-295.34%	↑ 594.14%

	Q4 FY23	Q/Q Change
Revenue	$24.6M	↑ 36.91%
Net Income	$-94.5M	↑ 78.0%
Net Profit Margin	-383.98%	↓ 88.64%

	Q1 FY24	Q/Q Change
Revenue	$13.4M	↓ 45.17%
Net Income	$-76.7M	↓ 18.58%
Net Profit Margin	-570.22%	↓ 186.24%

	Q2 FY24	Q/Q Change
Revenue	$15.5M	↑ 16.67%
Net Income	$-78.1M	↑ 2.82%
Net Profit Margin	-502.51%	↑ 67.71%

	Q3 FY24	Q/Q Change
Revenue	$493.9M	↑ 3321.32%
Net Income	$338.0M	↓ 565.99%
Net Profit Margin	68.44%	↑ 570.95%

	FY18	Y/Y Change
Profit	$-5.5M	-

	FY19	Y/Y Change
Profit	$-11.7M	↑ 116.85%

	FY20	Y/Y Change
Profit	$42.2M	↓ 428.64%

	FY21	Y/Y Change
Profit	$-152.8M	↓ 489.34%

	FY22	Y/Y Change
Profit	$-123.4M	↓ 13.78%

	FY23	Y/Y Change
Profit	$-77.0M	↓ 39.43%

	Q2 FY23	Q/Q Change
Profit	$-19.8M	↓ 73.25%

	Q3 FY23	Q/Q Change
Profit	$-8.3M	↓ 57.33%

	Q4 FY23	Q/Q Change
Profit	$-33.9M	↑ 297.92%

	Q1 FY24	Q/Q Change
Profit	$-31.9M	↓ 5.52%

	Q2 FY24	Q/Q Change
Profit	$-28.3M	↓ 10.33%

	Q3 FY24	Q/Q Change
Profit	$472.0M	↓ 1895.45%

	FY18	Y/Y Change
Operating Cash Flow	$-84.3M	-
Investing Cash Flow	$-4.9M	-
Financing Cash Flow	$-127.4K	-

	FY19	Y/Y Change
Operating Cash Flow	$-96.6M	↑ 17.34%
Investing Cash Flow	$31.3M	↓ 760.91%
Financing Cash Flow	$75.5M	↓ 60795.54%

	FY20	Y/Y Change
Operating Cash Flow	$635.4M	↓ 700.72%
Investing Cash Flow	$-55.1M	↓ 260.65%
Financing Cash Flow	$997.2M	↑ 1106.01%

	FY21	Y/Y Change
Operating Cash Flow	$-828.8M	↓ 240.34%
Investing Cash Flow	$-144.6M	↑ 182.5%
Financing Cash Flow	$390.0M	↓ 57.92%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-69.5M	↑ 30.62%
Investing Cash Flow	$-14.6M	↑ 0.0%
Financing Cash Flow	$-1.3M	↓ 103.59%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-64.7M	↓ 5.52%
Investing Cash Flow	$-14.3M	↑ 0.0%
Financing Cash Flow	$-1.3M	↑ 1.25%

Curevac Technicals Summary

Sell

Neutral

Buy

Curevac is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Curevac Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Curevac	4.18%	-12.06%	-30.14%	-91.27%	-94.65%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.02%	-18.97%	11.91%	91.19%
Biontech Se	-3.72%	42.02%	7.95%	-52.72%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	0.1%	24.29%	44.19%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-12.92%	-0.27%	83.92%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Curevac	6.1	6.1	NA	0.88	-0.54	-0.25	NA	1.68
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Curevac	Buy	$670.8M	-94.65%	6.1	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Curevac

founded in 2000 as a spin-off from the university of tϋbingen in germany, curevac is a leading company in the field of mrna technology and was the first company to start clin-ical trials on mrna-based drugs. the biopharmaceutical company has more than 17 years of expertise in handling and optimizing this versatile molecule for medical purposes. the basic principle of curevac's proprietary technology is the use of mrna as a data car-rier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. the company applies its technologies for the development of cancer therapies, prophylactic vaccines and molecular therapies. since its inception, strongly backed by sap founder dietmar hopp’s dievini, curevac has received approximately $420 million (€400 million) in equity investments including an investment of the bill & melinda gates foundation of $ 52million in 2015. curevac has entered into various collaborations with multinational corporations and o

Organization	Curevac
Employees	999
CEO	Dr. Alexander Zehnder M.B.A., M.D.
Industry	Health Technology

Management People of Curevac

Name	Title
Dr. Alexander Zehnder M.B.A., M.D.	CEO, MD & Member of Management Board
Dr. Malte Greune Ph.D.	COO, Member of Management Board & MD
Dr. Myriam Mendila M.D.	Chief Scientific Officer, Head of R&D, MD & Member of the Management Board
Dr. Ulrike Gnad-Vogt M.D., Ph.D.	Senior VP & Area Head of Oncology
Mr. Axel-Sven Malkomes	CFO & Member of Executive Board
Mr. Thaminda Ramanayake	Chief Business Officer & Member of Executive Board
Dr. Sarah Fakih	Vice President Corporate Communications & Investor Relations
Mr. Marco Rau L.L.M., Ph.D.	General Counsel
Mr. Thorsten Schuller	Head of Corporate Communications
Slavica Stevanovic-Heck	Head of Human Resources

Important FAQs about investing in Curevac from India :

What is Curevac share price today?

Curevac share price today stands at $3.05, Open: $2.97 ; Previous Close: $2.99 ; High: $3.06 ; Low: $2.94 ; 52 Week High: $5.28 ; 52 Week Low: $2.22. The stock opens at $2.97, after a previous close of $2.99. The stock reached a daily high of $3.06 and a low of $2.94, with a 52-week high of $5.28 and a 52-week low of $2.22.

Can Indians buy Curevac shares?

Yes, Indians can invest in the Curevac (CVAC) from India.

With INDmoney, you can buy Curevac at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Curevac at zero transaction cost.

How can I buy Curevac shares from India?

It is very easy to buy Curevac from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Curevac be purchased?

Yes, you can buy fractional shares of Curevac with INDmoney app.

What are the documents required to start investing in Curevac stocks?

To start investing in Curevac, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.